Gershenson, D. M., Miller, A., Brady, W., Paul, J., Carty, K., Rodgers, W., … Gourley, C. (2019). A randomized phase II/III study to assess the efficacy of trametinib in patients with recurrent or progressive low-grade serous ovarian or peritoneal cancer. In ANNALS OF ONCOLOGY (Vol. 30). Barcelona, SPAIN: OXFORD UNIV PRESS.

Gershenson, D. M., A. Miller, W. Brady, J. Paul, K. Carty, W. Rodgers, D. Millan, et al. “A randomized phase II/III study to assess the efficacy of trametinib in patients with recurrent or progressive low-grade serous ovarian or peritoneal cancer.” In ANNALS OF ONCOLOGY, Vol. 30. OXFORD UNIV PRESS, 2019.

Gershenson DM, Miller A, Brady W, Paul J, Carty K, Rodgers W, et al. A randomized phase II/III study to assess the efficacy of trametinib in patients with recurrent or progressive low-grade serous ovarian or peritoneal cancer. In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2019.

Gershenson, D. M., et al. “A randomized phase II/III study to assess the efficacy of trametinib in patients with recurrent or progressive low-grade serous ovarian or peritoneal cancer.” ANNALS OF ONCOLOGY, vol. 30, OXFORD UNIV PRESS, 2019.

Gershenson DM, Miller A, Brady W, Paul J, Carty K, Rodgers W, Millan D, Coleman RL, Moore KN, Banerjee S, Connolly K, Secord AA, O’Malley DM, Dorigo O, Gaillard S, Gabra H, Hanjani P, Huang H, Wenzel L, Gourley C. A randomized phase II/III study to assess the efficacy of trametinib in patients with recurrent or progressive low-grade serous ovarian or peritoneal cancer. ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2019.